Synapse - Elsevier Science, Inc.

Elsevier Science, Inc.

SHERPA: Unknown

People

Lilja
Vickers
Assel
Carlsson

Groups

Epidemiology and Biostatistics (3)
Health Outcomes Research Group (3)
Population Sciences Research Program (3)
Sloan Kettering Institute Postdocs (3)
Surgery (3)
Urology (3)

Results (3)

Twenty-year risk of prostate cancer death by midlife prostate-specific antigen and a panel of four kallikrein markers in a large population-based cohort of healthy men

Journal Article

Sjoberg, D. D.; Vickers, A. J.; Assel, M.; Dahlin, A.; Poon, B. Y.; Ulmert, D.; Lilja, H.
European Urology (2018)

Fulltext@MSK | Save

Association between lead time and prostate cancer grade: Evidence of grade progression from long-term follow-up of large population-based cohorts not subject to prostate-specific antigen screening

Journal Article

Assel, M.; Dahlin, A.; Ulmert, D.; Bergh, A.; Stattin, P.; Lilja, H.; Vickers, A. J.
European Urology (2018)

Fulltext@MSK | Save

Screening for prostate cancer starting at age 50–54 Years. A population-based cohort study

Journal Article

Carlsson, S.; Assel, M.; Ulmert, D.; Gerdtsson, A.; Hugosson, J.; Vickers, A.; Lilja, H.
European Urology (2017)

Fulltext@MSK | Save

Elsevier Science, Inc.

People

Groups

Results (3)

Journal Article

Journal Article

Journal Article

Elsevier Science, Inc. – authorized name for: